Perrigo Company (NYSE:PRGO) – Equities researchers at Leerink Swann issued their Q1 2018 earnings per share estimates for shares of Perrigo in a research report issued on Tuesday, Zacks Investment Research reports. Leerink Swann analyst A. Fadia expects that the company will post earnings per share of $1.13 for the quarter. Leerink Swann currently has a “Market Perform” rating and a $90.00 target price on the stock. Leerink Swann also issued estimates for Perrigo’s Q2 2018 earnings at $1.34 EPS, Q3 2018 earnings at $1.44 EPS, Q4 2018 earnings at $1.49 EPS and FY2022 earnings at $6.42 EPS.
Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Thursday, November 9th. The company reported $1.39 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.28. The business had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.17 billion. Perrigo had a positive return on equity of 11.60% and a negative net margin of 26.28%. The firm’s revenue was down 2.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.65 EPS.
A number of other equities analysts have also recently issued reports on PRGO. Oppenheimer initiated coverage on Perrigo in a report on Monday, October 2nd. They set a “buy” rating and a $88.00 target price for the company. UBS Group reiterated a “buy” rating and set a $98.00 target price (up previously from $84.00) on shares of Perrigo in a report on Thursday, October 5th. Cantor Fitzgerald set a $107.00 target price on Perrigo and gave the stock a “buy” rating in a report on Friday, October 20th. BidaskClub cut Perrigo from a “hold” rating to a “sell” rating in a report on Thursday, October 26th. Finally, Jefferies Group set a $71.00 target price on Perrigo and gave the stock a “hold” rating in a report on Sunday, October 29th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $92.00.
Shares of Perrigo (NYSE PRGO) traded up $0.56 during trading on Thursday, reaching $95.15. The company had a trading volume of 975,706 shares, compared to its average volume of 994,253. The firm has a market cap of $13,320.00, a P/E ratio of -10.39, a PEG ratio of 2.01 and a beta of 0.64. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.72 and a quick ratio of 1.24. Perrigo has a twelve month low of $63.68 and a twelve month high of $95.93.
In other news, VP Todd W. Kingma sold 1,500 shares of the firm’s stock in a transaction dated Friday, December 28th. The stock was sold at an average price of $88.52, for a total value of $132,780.00. Following the completion of the transaction, the vice president now owns 19,565 shares in the company, valued at approximately $1,731,893.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP John Wesolowski sold 450 shares of Perrigo stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $83.09, for a total value of $37,390.50. The disclosure for this sale can be found here. Insiders sold a total of 4,051 shares of company stock valued at $355,370 in the last 90 days. 6.90% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of the stock. Parsec Financial Management Inc. grew its holdings in Perrigo by 24.2% during the fourth quarter. Parsec Financial Management Inc. now owns 47,733 shares of the company’s stock worth $4,160,000 after purchasing an additional 9,301 shares during the period. Robeco Institutional Asset Management B.V. grew its holdings in Perrigo by 60.2% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 52,733 shares of the company’s stock worth $4,596,000 after purchasing an additional 19,821 shares during the period. Lourd Capital LLC bought a new position in Perrigo during the fourth quarter worth about $216,000. Assenagon Asset Management S.A. bought a new position in Perrigo during the fourth quarter worth about $4,451,000. Finally, Cortland Associates Inc. MO grew its holdings in Perrigo by 3.1% during the fourth quarter. Cortland Associates Inc. MO now owns 115,411 shares of the company’s stock worth $10,059,000 after purchasing an additional 3,509 shares during the period. Institutional investors and hedge funds own 83.33% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/01/28/q1-2018-earnings-estimate-for-perrigo-company-prgo-issued-by-leerink-swann.html.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Get a free copy of the Zacks research report on Perrigo (PRGO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.